At the event, ECARX’s management showcased the Company’s breakeven at the EBITDA level during the fourth quarter of 2024, its confidence in delivering positive EBITDA for the full year 2025, and its ...
Full Year 2024 and Recent Business HighlightsFull Year Consolidated Sales Grew 18% Year-over-Year to $336.2 Million2024 Canadian Cannabis Sales ...
Q4 2024 Earnings Call Transcript March 11, 2025 Operator: Good afternoon, ladies and gentlemen, and welcome to the Zynex ...
Q4 2024 Earnings Call Transcript March 11, 2025 Zevra Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0 ...
Q4 2024 Earnings Call Transcript March 11, 2025 Exagen Inc. beats earnings expectations. Reported EPS is $-0.2, expectations ...
Q4 2024 Earnings Call Transcript March 11, 2025 Allbirds, Inc. beats earnings expectations. Reported EPS is $-3.23, ...
Q4 2024 Earnings Call Transcript March 11, 2025 MaxCyte, Inc. beats earnings expectations. Reported EPS is $-0.1004, ...
Q4 2024 Earnings Call Transcript March 11, 2025 Kanzhun Limited beats earnings expectations. Reported EPS is $1.58, ...
Q4 2024 Earnings Call Transcript March 11, 2025 CuriosityStream Inc. misses on earnings expectations. Reported EPS is $-0.05 ...
Q4 2024 Earnings Call Transcript March 11, 2025 RumbleON, Inc. misses on earnings expectations. Reported EPS is $-1.58 EPS, ...
Ladies and gentlemen, thank you for standing by. Welcome to the Eltek Ltd. 2024 Annual and Fourth Quarter Financial Results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback